ライフサイエンスコーパス: commercialization

1 nal) and operational status of dispensaries (commercialization).

2 of perovskite thin films towards large-scale commercialization.

3 eptor blocker users before and after generic commercialization.

4 <0.0001), respectively, the month of generic commercialization.

5 nges to overcome before reaching large-scale commercialization.

6 potential barrier to production scale-up and commercialization.

7 tial applications and some that have reached commercialization.

8 der realistic environments to speed up their commercialization.

9 ve been hindered with major setbacks towards commercialization.

10 te) make this idea very promising for future commercialization.

11 surge of investments in drug development and commercialization.

12 ternal stimuli, considerably hampering their commercialization.

13 ch and leafy beets) at costs that will allow commercialization.

14 es that might bring perovskite technology to commercialization.

15 ature selection for data classification, and commercialization.

16 ly desired for industrial implementation and commercialization.

17 eventing biochemical/physical changes during commercialization.

18 rmation renders this approach unsuitable for commercialization.

19 development to achieve an efficient means to commercialization.

20 technology is far from maturity and, hence, commercialization.

21 ptable for decades are suddenly critical for commercialization.

22 ch and development will be required for E-BC commercialization.

23 ccessful clinical translation and widespread commercialization.

24 stry made strong progress in translation and commercialization.

25 es microbial electrosynthesis systems toward commercialization.

26 plications, and fewer have progressed toward commercialization.

27 de fixation are the main limitations for its commercialization.

28 applications, which hold great potential for commercialization.

29 and scarcity are prohibitive to large-scale commercialization.

30 romising performance characteristics for RFB commercialization.

31 oven to be sufficiently effective to warrant commercialization.

32 alve in consecutive patients in Europe after commercialization.

33 rd for microalgae-based biofuel research and commercialization.

34 l for an economically successful large-scale commercialization.

35 assay optimization, biomarker validation and commercialization.

36 needs to be disclosed during development and commercialization.

37 of new vaccines and is central to successful commercialization.

38 t progress in terms of clinical outcomes and commercialization.

39 ed in the variety development process before commercialization.

40 s rely extensively on strain improvement for commercialization.

41 prospects for future research directions and commercialization.

42 ergy and for their potential for large-scale commercialization.

43 ilability to make them viable candidates for commercialization.

44 or feasibility, and otherwise applied toward commercialization.

45 trait genes into high-yielding germplasm for commercialization.

46 al study site through multicenter trials and commercialization.

47 ntrols required for clinical translation and commercialization.

48 Ps on multiple levels during development and commercialization.

49 anding of the translational vector for their commercialization.

50 the current status of scale-up synthesis and commercialization.

51 ts in drug delivery, device development, and commercialization.

52 proach, have shown promising advances toward commercialization.

53 e retaining high selectivity is critical for commercialization.

54 e strategies to facilitate their large-scale commercialization.

55 the challenges of scaling up production for commercialization.

56 will be critical for product development and commercialization.

57 kite solar cells (PSCs) is crucial for their commercialization.

58 logical and long-term stability analyses for commercialization.

59 , however, the stability issue hinders their commercialization.

60 nabling a more rapid transition to scale and commercialization.

61 egulatory guidelines of genome editing curbs commercialization.

62 ich may slow down or even hinder the pace of commercialization.

63 of chemical sensors and their prospects for commercialization.

64 m stability remains a major concern prior to commercialization.

65 y of ~23%, fulfilling their potential toward commercialization.

66 e to coke formation which has hindered their commercialization.

67 f paramount importance for their large-scale commercialization.

68 ssessments of food enzymes (FE) before their commercialization.

69 these laboratory-based achievements to reach commercialization.

70 ill remain that may potentially hinder their commercialization.

71 g interest in its national and international commercialization.

72 nds, production efficiencies are too low for commercialization.

73 ce on BPH and PWS should be conducted before commercialization.

74 acile approach, economical and potential for commercialization.

75 7%-3.4%]; P=0.0033) </=1 year after generics commercialization.

76 nar metal complexes can be stable enough for commercialization.

77 4 months before and 12 months after generics commercialization.

78 s or reaction media that are not amenable to commercialization.

79 gy(1-6), face obstacles on their way towards commercialization.

80 , phytoextraction has yet to see significant commercialization.

81 heir various applications, and potential for commercialization across a broad spectrum of fields.

82 s have not considered variations in cannabis commercialization across states over time.

83 rs potentially enhance faculty engagement in commercialization activities?

84 ir criteria to treat patents, licensing, and commercialization activity by faculty as an important co

85 correlated with the potential for increased commercialization activity.

86 tages when viewed with a mindset of ultimate commercialization and clinical utility.

87 itial studies were promising, the pathway to commercialization and deployment in a clinical setting h

88 ities produces S. ramosissima plants fit for commercialization and human consumption.

89 operties of EVOOs are very relevant to their commercialization and increase the product value.

90 that would tip the value proposition toward commercialization and meaningful adoption.

91 has not been very successful with regard to commercialization and public acceptance.

92 Commercialization and the COVID-19 pandemic were associa

93 Finally, we discuss the barriers toward commercialization and the next generation of LFAs.

94 Nevertheless, successful commercialization and widespread implementation of such

95 Catalyst-electrode design is crucial for the commercialization and widespread use of polymer electrol

96 phase III technology to make it feasible for commercialization and widespread use.

97 mristor unpredictability that have inhibited commercialization, and can, therefore, enable unpreceden

98 the progress that has been made toward their commercialization, and the major challenges facing their

99 to be met to move advanced biofuels towards commercialization, and to compete with more conventional

100 By 2005, human organ trafficking, commercialization, and transplant tourism had become a p

101 imitations in formulation, registration, and commercialization are discussed, along with suggested fu

102 Commercialization aspects, including cost and durability

103 es have assessed outcomes after generic drug commercialization at a population level.

104 ns support high-risk, early-stage technology commercialization at small businesses.

105 the barriers associated with cancer research commercialization at the University of Kentucky (UK).

106 iple barriers likely inhibit cancer research commercialization at UK with expense, time, infrastructu

107 general barriers inhibiting cancer research commercialization at UK? and 2) Would mitigation of the

108 to mitigate common impediments to practical commercialization but is also placed in context with tra

109 de fuel cells is critical to their increased commercialization but is inhibited by the slow oxygen ex

110 sorbers have emerged as the frontrunners for commercialization, but commercial success is reliant on

111 rocedures, risk mitigation, more emphasis on commercialization by academia research field, and increa

112 challenges still have to be overcome before commercialization can be achieved.

113 rials and approached regulatory approval and commercialization, Codexis and Schering-Plough (now Merc

114 Commercialization/COVID-19 was associated with a greater

115 ng for time trends before legalization, only commercialization/COVID-19 was associated with increased

116 cumbersome user interfaces, which all render commercialization difficult.

117 Third, despite trends toward commercialization, easier lives, and self-centered indiv

118 Tremendous research and commercialization efforts around the world are focused o

119 ges still need to be overcome for any future commercialization efforts of these novel therapies to be

120 rthermore, the applications, data analytics, commercialization efforts, challenges, and prospects of

121 ents rates were observed right after generic commercialization for 3 antihypertensive drugs.

122 able electronic devices; and perspectives of commercialization for flexible perovskite solar cells ba

123 re either already commercialized or close to commercialization for hybrid electric vehicle applicatio

124 besides being ecofriendly which allows their commercialization for public consumers in fast detection

125 However, its commercialization has been hindered due to the high manu

126 However, its commercialization has been impeded by the severe safety

127 As commercialization has lowered the barrier to using SRM a

128 shift of academic biomedical science toward commercialization has occurred, spurred by U.S. federal

129 erformed well over the past ten years, their commercialization has yet to take place for a variety of

130 all medicinal chemistry efforts and eventual commercialization have relied upon natural (plant materi

131 ng the treatment capacity and feasibility of commercialization, HHP would be a promising technology i

132 ncy has already reached the level needed for commercialization; however, the instability hinders its

133 Since its commercialization in 2007, the number of TAVR procedures

134 ncile the needs for both personalization and commercialization in a manner that is unique to each pat

135 the growing unprecedented demand of LIBs for commercialization in EVs and grid-scale energy storage s

136 could provide valuable information for their commercialization in future foods.

137 ying all the requirements for its successful commercialization in synchrotron and medical imaging.

138 S. Food and Drug Administration approval for commercialization in the near future.

139 r transplantation has effectively eliminated commercialization in transplantation in the state of Tam

140 Traits of ALCBs that favored their commercialization include gregarious nesting; use of lea

141 Challenges and pitfalls of commercialization include reliance on findings from shor

142 that limit their widespread translation and commercialization, including identification of the appro

143 genetically modified organisms (GMOs), their commercialization is by no means certain at this time.

144 mate solutions for renewable energy, but its commercialization is hindered by growth limitations caus

145 s for a sustainable energy future, but their commercialization is hindered by the absence of cost-eff

146 cine and alleviate global health crises, yet commercialization is often wrought by competing forces.

147 However, commercialization is prevented by impractical and expens

148 A major impediment to Li-O(2) battery commercialization is the low discharge capacities result

149 linical results, polymeric HVs did not reach commercialization, mainly owing to their limited durabil

150 es of their customers during development and commercialization may be ineffective to promote trust an

151 conclude with some perspectives on routes to commercialization, new device opportunities, and remaini

152 itals following the Edwards Sapien XT device commercialization (November 2011-May 2013).

153 Three decades of progress led to the commercialization of 2.5 Gbit s(-1)-per-channel submarin

154 cellulose hydrolysis represents a barrier to commercialization of a biorefinery capable of producing

155 Nonetheless, to pave the way toward commercialization of adsorption-based CO2 capture techno

156 inting MO electronics and, most importantly, commercialization of amorphous oxide semiconductors for

157 property facilitated wide dissemination and commercialization of antibody technology.

158 Successful commercialization of any biotechnology usually requires

159 y and stable cathodes is a key to successful commercialization of aqueous Zn-ion batteries (ZIBs).

160 quity, but with the recent rapidly expanding commercialization of art, the approach to art authentica

161 Finally, some challenges regarding the commercialization of AuNPs in future medicine such as, c

162 of such strategies can pave the way for the commercialization of bio-based chemicals.

163 enzymes remains a key economic impediment to commercialization of biofuels.

164 The development and commercialization of bioherbicides in affluent countries

165 s of research, including the development and commercialization of biological therapeutics.

166 indings were the most important obstacles to commercialization of biomarker tests.

167 Commercialization of biomass refining is imminent but th

168 nsors, there are substantial barriers to the commercialization of biomedical devices.

169 apital available to fund the development and commercialization of biomedical innovations, and to high

170 tion methods will be required for successful commercialization of bioprocesses.

171 al of the first biosimilar drug in 2015, the commercialization of biosimilars has been limited.

172 ping, and storage, and can potentially delay commercialization of candidates.

173 Although commercialization of CNT-enabled products is increasing,

174 increase in cross-disciplinary research, the commercialization of cognitive neuroscience, the impetus

175 ture perspective for further improvement and commercialization of creatinine biosensors are discussed

176 The commercialization of declared blends of olive oil and se

177 However, commercialization of direct ethanol fuel cells has been

178 d skills development in venture creation and commercialization of discoveries.

179 increasing interest for feasible large-scale commercialization of DSSCs due to their more favorable l

180 rogram them directly into memristors for the commercialization of edge applications.

181 based light-emitting diodes have enabled the commercialization of efficient solid-state lighting devi

182 The main obstacles toward further commercialization of electrochemical devices are the dev

183 The commercialization of electrospray interfaces for liquid

184 ce of considering waste recycling before the commercialization of emerging PV technologies(1,2).

185 of charge and discharge are major hurdles to commercialization of energy-storage devices based on eac

186 e Anthropocene through industrialization and commercialization of fisheries throughout the medieval p

187 safety and regulatory issues related to the commercialization of FPH as a protein ingredient in food

188 llic catalysts, which can pave a way for the commercialization of fuel cell technologies.

189 oxidation reaction is very important for the commercialization of fuel cells, but still a great chall

190 place PtRu NCs is a critical step toward the commercialization of fuel cells.

191 The steady increase in commercialization of genetically modified organisms (GMO

192 tates and other parts of the world after the commercialization of glyphosate-resistant crops.

193 supporting information needed for successful commercialization of GM sugarcane.

194 ade ago prompted the strong push towards the commercialization of graphene as evidenced by a wealth o

195 This Review discusses the progress towards commercialization of graphene for the past decade and fu

196 ) under alkaline conditions has hindered the commercialization of hydroxide-exchange membrane hydroge

197 rtable diagnostic devices and accelerate the commercialization of lab-on-a-chip devices.

198 ectrodes are excellent HER electrocatalysts, commercialization of large-scale hydrogen production tec

199 isks and short lifetime and thus impedes the commercialization of Li metal batteries.

200 deficiencies are significant barriers to the commercialization of LMP batteries.

201 nologies is promising for the production and commercialization of low cost sensors.

202 ect of carbon monoxide, opening the door for commercialization of low-temperature fuel cells that can

203 of the high-priority research directions for commercialization of low-temperature polymer electrolyte

204 This study could help promote the commercialization of Mexican genotypes of cocoa and repo

205 ery, low-cost power production, and thus the commercialization of MFCs.

206 ces, which contribute a lot to expansion and commercialization of MFCs.

207 We show that redox engineering could enable commercialization of microbial carbohydrate-based lipid

208 The rapid development and commercialization of nanomaterials will inevitably resul

209 The commercialization of nanoscale devices requires the deve

210 Scalable nanomanufacturing enables the commercialization of nanotechnology, particularly in app

211 In addtion, the potential challenges for commercialization of new DDS are presented.

212 de operating conditions severely impedes the commercialization of non-iridium (Ir) proton exchange me

213 A key challenge to the commercialization of organic bulk heterojunction solar c

214 stable photo-active layers, facilitating the commercialization of OSCs.

215 rocarbons, such as poly(perfluoroether), the commercialization of otherwise promising CO2-based proce

216 key issues that must be addressed before the commercialization of perovskite optoelectronic devices.

217 An important challenge in the commercialization of perovskite solar cells (PSCs) is th

218 Nevertheless, the development and commercialization of point-of-care combination tests cap

219 re diagnostics for home healthcare; however, commercialization of point-of-care devices has been limi

220 ant decline in power density and impedes the commercialization of PRO technology.

221 opment is an integral step in the successful commercialization of protein-based products in both the

222 The commercialization of proton exchange membrane fuel cells

223 o overcome the last technical barrier to the commercialization of Pt complexes for many applications.

224 , and the development of economic models for commercialization of rare disease therapies.

225 ction (OER) is paramount for the large-scale commercialization of renewable fuel cells and rechargeab

226 1.02; 95% CI, 1.01-1.03), and engagement in commercialization of research (OR, 2.45; 95% CI, 2.08-2.

227 ing the past decade have led to approval and commercialization of several microneedle based/assisted

228 is probably the last major challenge for the commercialization of solid-contact ion-selective electro

229 m block structures, making them suitable for commercialization of specialty polymers.

230 and practical applications still hinder the commercialization of SSLSBs.

231 ion reaction (OER) limit the performance and commercialization of such devices.

232 oblems that need to be resolved prior to any commercialization of such devices.

233 However, the scale-up commercialization of such materials is still a challenge

234 production of sustainable biofuels, but the commercialization of such products is hampered by the hi

235 ture perspective for further improvement and commercialization of TG biosensors are discussed.

236 One of the limiting factors in the commercialization of the bio-based polyesters, for examp

237 nd firm scientists were needed to accomplish commercialization of the breakthroughs.

238 ocatalyst has remained the challenge for the commercialization of the direct DME fuel cell.

239 ogress on power conversion efficiencies, the commercialization of the emerging lead (Pb) halide perov

240 , the increasingly problematic phenomenon of commercialization of the field of transplantation can be

241 hnology, 1995 and 1996 will be marked by the commercialization of the first genetically engineered pl

242 Commercialization of the lithium-sulfur battery is hampe

243 Overall the fabrication and commercialization of the nanohole array (NHA) setup to t

244 could be reproduced on a large scale for the commercialization of the products by the food industry.

245 d from IRGM rice basic research to potential commercialization of the world's first IRGM rice.

246 e of the solar reactor holds the key for the commercialization of thermochemical fuel production.

247 ation steps remain primary challenges to the commercialization of these biosensors.

248 nities as well as the characteristics of the commercialization of these captures in Portugal.

249 fuel cells and metal-air batteries limit the commercialization of these clean-energy technologies.

250 However, commercialization of these devices requires barriers to

251 ess, there are limits to the application and commercialization of these materials because of the diff

252 However, some hurdles remain prior to commercialization of these materials, such as chemical s

253 g rate, bringing the prospects of widespread commercialization of these novel and exciting materials

254 Though the commercialization of these sensors is currently limited,

255 spiro(TFSI)2 is an important step toward the commercialization of these technologies.

256 A major bottleneck delaying the further commercialization of thin-film solar cells based on hybr

257 can play a significant role in the eventual commercialization of this class of materials.

258 Furthermore, to address the need for future commercialization of this material, we demonstrate that

259 ht the current challenges in translation and commercialization of this technology for the pharmacolog

260 Commercialization of this technology requires reduction

261 perience from two decades of research on and commercialization of transgenic crops, and expanding kno

262 criteria are substantial impediments to the commercialization of transgenic crops.

263 ations, including field trials and potential commercialization of transgenic rice expressing a number

264 research relationship and engagement in the commercialization of university research were significan

265 Successful commercialization of wearable diagnostic sensors necessi

266 lopments and are driving the advancement and commercialization of wearable electrochemical sensors: f

267 Now that commercialization of YBCO-tape conductors is much closer

268 Research on, and commercialization of, cloned cattle has been conducted f

269 f 3 generic angiotensin II receptor blockers commercialization on adverse events: hospitalizations or

270 es, their stability remains a bottleneck for commercialization partly due to the use of doped Spiro-O

271 acturing obstacles, and the termination of a commercialization partnership have challenged the develo

272 ime, underscoring the importance of studying commercialization policy going forward.

273 y that has high salt rejection; however, its commercialization potential for applications such as sea

274 nut milk is a nutrient rich drink with great commercialization potential.

275 tus of PGx studies in psychiatry, review the commercialization process for PGx tests and then discuss

276 earch in terms of large scale production and commercialization prospects.

277 ental for the characterization of a drug for commercialization purposes and for the determination of

278 During commercialization, rates of CHS ED visits increased more

279 But taking the step towards successful commercialization requires oxygen reduction electrocatal

280 rsion efficiency and long-term stability for commercialization requires sustainable research effort.

281 " grapes, within normal conditions of market commercialization, responding to the rising consumers de

282 cal companies for subsequent development and commercialization results in prices that prioritize reco

283 ges of each technique, briefly discuss their commercialization status, and some technical issues that

284 identifies issues, and highlights successful commercialization strategies.

285 the need and future plans for identifying a commercialization strategy to overcome the major financi

286 are already in the market or on the verge of commercialization, such as disposable paper-based device

287 t PhD-holding respondents and respondents in commercialization-supportive research fields would be mo

288 or features of this new fiber concept before commercialization, the outcomes of this work serve to co

289 With several of these technologies nearing commercialization, there is a sense that the field of mi

290 d solar cells needs to be overcome for their commercialization to be viable.

291 high throughput and is perfectly suited for commercialization using batch processing.

292 At last, the Review offers an outlook for commercialization viability of memristive technology.

293 Periods before and after generics commercialization were compared by negative binomial seg

294 e in their electrolyte chemistry since their commercialization, which has limited improvements in dev

295 However, successful commercialization will require standardized manufacturin

296 Lastly we present the current state of MOF commercialization with direct feedback from commercial p

297 h product and retail store restrictions, and commercialization with new products and expanded number

298 h product and retail store restrictions, and commercialization with new products and expanded stores,

299 Commercialization within the academic setting is associa

300 gression modeling demonstrated that research commercialization would incrementally increase as barrie